Long-term treatment with clozapine and verbal memory performance in schizophrenia

Detalhes bibliográficos
Autor(a) principal: Czepielewski, Letícia Sanguinetti
Data de Publicação: 2018
Outros Autores: Londero, Marina Dalla Barba, Sousa, Mathias Hasse de, Perin, Carolina Petry, Maldonado, Helena Carvalho, Claudino, Felipe Cesar de Almeida, Gama, Clarissa Severino
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/201440
Resumo: Clozapine is more efficacious than first-generation antipsychotics for positive and negative symptoms, although it is related with serious adverse effects. Because of this profile, it could also have an impact on cognition. Therefore, we evaluated learning ability of 31 treatment-resistant individuals with SZ using clozapine uninterruptedly for 18.23 ± 4.71 years and 26 non-treatment-resistant using other antipsychotics that never used clozapine. Long-term treatment with clozapine did not improve verbal learning ability better than other antipsychotics. Although clozapine has a unique profile for reducing clinical symptoms, it may not have an additional benefit for cognition when started later on the course of schizophrenia.
id UFRGS-2_2f124fc144db4b4db93ec65d9f2da3bb
oai_identifier_str oai:www.lume.ufrgs.br:10183/201440
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Czepielewski, Letícia SanguinettiLondero, Marina Dalla BarbaSousa, Mathias Hasse dePerin, Carolina PetryMaldonado, Helena CarvalhoClaudino, Felipe Cesar de AlmeidaGama, Clarissa Severino2019-11-08T03:43:14Z20182215-0013http://hdl.handle.net/10183/201440001073498Clozapine is more efficacious than first-generation antipsychotics for positive and negative symptoms, although it is related with serious adverse effects. Because of this profile, it could also have an impact on cognition. Therefore, we evaluated learning ability of 31 treatment-resistant individuals with SZ using clozapine uninterruptedly for 18.23 ± 4.71 years and 26 non-treatment-resistant using other antipsychotics that never used clozapine. Long-term treatment with clozapine did not improve verbal learning ability better than other antipsychotics. Although clozapine has a unique profile for reducing clinical symptoms, it may not have an additional benefit for cognition when started later on the course of schizophrenia.application/pdfengSchizophrenia research : cognition. New York. Vol. 12 (June 2018), p. 40-41ClozapinaEsquizofreniaAntipsicóticosLong-term treatment with clozapine and verbal memory performance in schizophreniaEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001073498.pdf.txt001073498.pdf.txtExtracted Texttext/plain10323http://www.lume.ufrgs.br/bitstream/10183/201440/2/001073498.pdf.txt07de551cde879806a7984440fae09f9aMD52ORIGINAL001073498.pdfTexto completo (inglês)application/pdf164040http://www.lume.ufrgs.br/bitstream/10183/201440/1/001073498.pdfa9bc2453f53413bbed94ca71492c3b6aMD5110183/2014402023-11-05 04:24:30.083987oai:www.lume.ufrgs.br:10183/201440Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2023-11-05T06:24:30Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Long-term treatment with clozapine and verbal memory performance in schizophrenia
title Long-term treatment with clozapine and verbal memory performance in schizophrenia
spellingShingle Long-term treatment with clozapine and verbal memory performance in schizophrenia
Czepielewski, Letícia Sanguinetti
Clozapina
Esquizofrenia
Antipsicóticos
title_short Long-term treatment with clozapine and verbal memory performance in schizophrenia
title_full Long-term treatment with clozapine and verbal memory performance in schizophrenia
title_fullStr Long-term treatment with clozapine and verbal memory performance in schizophrenia
title_full_unstemmed Long-term treatment with clozapine and verbal memory performance in schizophrenia
title_sort Long-term treatment with clozapine and verbal memory performance in schizophrenia
author Czepielewski, Letícia Sanguinetti
author_facet Czepielewski, Letícia Sanguinetti
Londero, Marina Dalla Barba
Sousa, Mathias Hasse de
Perin, Carolina Petry
Maldonado, Helena Carvalho
Claudino, Felipe Cesar de Almeida
Gama, Clarissa Severino
author_role author
author2 Londero, Marina Dalla Barba
Sousa, Mathias Hasse de
Perin, Carolina Petry
Maldonado, Helena Carvalho
Claudino, Felipe Cesar de Almeida
Gama, Clarissa Severino
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Czepielewski, Letícia Sanguinetti
Londero, Marina Dalla Barba
Sousa, Mathias Hasse de
Perin, Carolina Petry
Maldonado, Helena Carvalho
Claudino, Felipe Cesar de Almeida
Gama, Clarissa Severino
dc.subject.por.fl_str_mv Clozapina
Esquizofrenia
Antipsicóticos
topic Clozapina
Esquizofrenia
Antipsicóticos
description Clozapine is more efficacious than first-generation antipsychotics for positive and negative symptoms, although it is related with serious adverse effects. Because of this profile, it could also have an impact on cognition. Therefore, we evaluated learning ability of 31 treatment-resistant individuals with SZ using clozapine uninterruptedly for 18.23 ± 4.71 years and 26 non-treatment-resistant using other antipsychotics that never used clozapine. Long-term treatment with clozapine did not improve verbal learning ability better than other antipsychotics. Although clozapine has a unique profile for reducing clinical symptoms, it may not have an additional benefit for cognition when started later on the course of schizophrenia.
publishDate 2018
dc.date.issued.fl_str_mv 2018
dc.date.accessioned.fl_str_mv 2019-11-08T03:43:14Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/201440
dc.identifier.issn.pt_BR.fl_str_mv 2215-0013
dc.identifier.nrb.pt_BR.fl_str_mv 001073498
identifier_str_mv 2215-0013
001073498
url http://hdl.handle.net/10183/201440
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Schizophrenia research : cognition. New York. Vol. 12 (June 2018), p. 40-41
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/201440/2/001073498.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/201440/1/001073498.pdf
bitstream.checksum.fl_str_mv 07de551cde879806a7984440fae09f9a
a9bc2453f53413bbed94ca71492c3b6a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1798487417346326528

Registros relacionados